Insider Trading & Ownership of James E. Dentzer

Location
Cranbury, NJ
Summary
The estimated net worth of James E. Dentzer is at least $1,322,415 dollars as of 23 Mar 2026. James E. Dentzer is the President & CEO, Director of CURIS INC and owns shares of CURIS INC (CRIS) stock worth about $1.29M. James E. Dentzer is the Director of Imunon, Inc. and owns shares of Imunon, Inc. (IMNN) stock worth about $30.5K.
Signature
/s/ Diantha Duvall, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow James E. Dentzer and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • James E. Dentzer has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,322,415.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CURIS INC ($1,291,890).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of James E. Dentzer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRIS CURIS INC President & CEO, Director $1,291,890 20 Mar 2026
IMNN Imunon, Inc. Director $30,525 02 Jan 2026

Insider Transactions Reported by James E. Dentzer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .